US Stock MarketDetailed Quotes

Structure Therapeutics (GPCR)

Watchlist
  • 54.510
  • -0.630-1.14%
Close Apr 10 16:00 ET
  • 54.300
  • -0.210-0.39%
Post 20:01 ET
3.86BMarket Cap-22.71P/E (TTM)

Structure Therapeutics (GPCR) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-90.51%-222.2M
-76.64%-64.42M
-158.92%-51M
-106.71%-54.56M
-53.25%-52.23M
-46.73%-116.64M
-67.83%-36.47M
4.19%-19.7M
-56.23%-26.39M
-67.82%-34.08M
Net income from continuing operations
-15.24%-141.2M
190.47%33M
-93.40%-65.71M
-136.85%-61.66M
-79.88%-46.83M
-36.72%-122.53M
-48.88%-36.48M
-42.39%-33.98M
-11.83%-26.03M
-44.85%-26.04M
Operating gains losses
---10.25M
----
----
----
----
----
----
----
----
----
Depreciation and amortization
34.38%1.33M
50.92%412K
34.34%356K
25.43%291K
23.42%274K
236.27%992K
279.17%273K
235.44%265K
213.51%232K
217.14%222K
Other non cash items
59.25%2.56M
101.28%940K
139.41%644K
29.93%560K
-5.94%412K
145.04%1.61M
125.60%467K
-2.54%269K
389.77%431K
421.43%438K
Change In working capital
-3,070.34%-88.04M
-17,471.72%-93.83M
-30.58%9.51M
251.57%3.08M
16.74%-6.8M
-57.45%2.96M
-119.63%-534K
397.75%13.7M
-132.99%-2.03M
-74.82%-8.17M
-Change in receivables
---100M
----
----
----
----
--0
----
----
----
----
-Change in prepaid assets
-1,065.70%-16.41M
-1,458.18%-9.13M
-201.87%-2.18M
-102.57%-62K
23.83%-5.05M
65.12%-1.41M
138.40%672K
337.44%2.14M
45.30%2.41M
-117.60%-6.63M
-Change in payables and accrued expense
138.38%26.28M
285.04%10.02M
7.05%12.69M
275.51%3.88M
74.73%-307K
-2.47%11.02M
-42.82%2.6M
219.43%11.85M
-148.94%-2.21M
17.79%-1.22M
-Change in other current assets
186.72%4.39M
279.11%5.88M
-10,025.00%-397K
94.04%-106K
-49,400.00%-990K
-33,840.00%-5.06M
-46,814.29%-3.28M
--4K
-2,296.30%-1.78M
96.61%-2K
-Change in other current liabilities
-44.31%-2.3M
-15.30%-603K
-107.96%-601K
-40.35%-633K
-39.94%-459K
-405.08%-1.59M
-636.62%-523K
-407.02%-289K
-374.74%-451K
-256.52%-328K
Cash from discontinued investing activities
Operating cash flow
-90.51%-222.2M
-76.64%-64.42M
-158.92%-51M
-106.71%-54.56M
-53.25%-52.23M
-46.73%-116.64M
-67.83%-36.47M
4.19%-19.7M
-56.23%-26.39M
-67.82%-34.08M
Investing cash flow
Cash flow from continuing investing activities
125.02%89.8M
68.93%56.14M
73.91%-49.32M
123.93%48.94M
2,300.07%34.03M
-33.75%-358.91M
118.39%33.23M
-727.45%-189.04M
-197.65%-204.52M
102.89%1.42M
Net PPE purchase and sale
-180.16%-3.61M
-9,250.00%-1.5M
-129.49%-1.57M
45.67%-232K
-93.83%-314K
40.47%-1.29M
98.62%-16K
16.46%-685K
-123.56%-427K
---162K
Net investment purchase and sale
126.12%93.41M
88.87%62.79M
71.91%-52.91M
124.09%49.17M
2,073.86%34.35M
-34.35%-357.62M
118.51%33.25M
-708.61%-188.36M
-197.85%-204.09M
103.22%1.58M
Cash from discontinued investing activities
Investing cash flow
125.02%89.8M
68.93%56.14M
73.91%-49.32M
123.93%48.94M
2,300.07%34.03M
-33.75%-358.91M
118.39%33.23M
-727.45%-189.04M
-197.65%-204.52M
102.89%1.42M
Financing cash flow
Cash flow from continuing financing activities
47.99%762.52M
114,532.03%704.99M
7,524.44%56.2M
-99.90%517K
15.24%809K
14.11%515.26M
-99.78%615K
-260.04%-757K
173,400.67%514.7M
-99.59%702K
Net common stock issuance
29.37%665.71M
--608.65M
--57.06M
----
----
8.95%514.57M
--0
--0
--514.57M
--0
Proceeds from stock option exercised by employees
3,900.24%99.45M
15,767.80%97.59M
-5.04%377K
-28.09%517K
27.81%965K
210.75%2.49M
425.64%615K
-16.07%397K
301.68%719K
2,335.48%755K
Net other financing activities
-46.88%-2.64M
---1.25M
-6.76%-1.23M
--0
-194.34%-156K
91.67%-1.8M
--0
---1.15M
-23.74%-589K
97.96%-53K
Cash from discontinued financing activities
Financing cash flow
47.99%762.52M
114,532.03%704.99M
7,524.44%56.2M
-99.90%517K
15.24%809K
14.11%515.26M
-99.78%615K
-260.04%-757K
173,400.67%514.7M
-99.59%702K
Net cash flow
Beginning cash position
30.60%169.51M
-40.21%102.91M
-61.47%147.02M
55.49%152.12M
30.60%169.51M
397.46%129.79M
239.94%172.13M
840.18%381.63M
-22.66%97.83M
397.46%129.79M
Current changes in cash
1,486.47%630.11M
26,692.02%696.71M
78.94%-44.11M
-101.80%-5.1M
45.60%-17.39M
-61.70%39.72M
-103.31%-2.62M
-2,185.58%-209.5M
430.37%283.8M
-131.83%-31.96M
End cash Position
371.73%799.62M
371.73%799.62M
-40.21%102.91M
-61.47%147.02M
55.49%152.12M
30.60%169.51M
30.60%169.51M
239.94%172.13M
840.18%381.63M
-22.66%97.83M
Free cash flow
-91.49%-225.81M
-80.66%-65.91M
-157.93%-52.57M
-104.29%-54.79M
-53.45%-52.54M
-44.42%-117.93M
-59.42%-36.48M
4.66%-20.38M
-56.98%-26.82M
-68.61%-34.24M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -90.51%-222.2M-76.64%-64.42M-158.92%-51M-106.71%-54.56M-53.25%-52.23M-46.73%-116.64M-67.83%-36.47M4.19%-19.7M-56.23%-26.39M-67.82%-34.08M
Net income from continuing operations -15.24%-141.2M190.47%33M-93.40%-65.71M-136.85%-61.66M-79.88%-46.83M-36.72%-122.53M-48.88%-36.48M-42.39%-33.98M-11.83%-26.03M-44.85%-26.04M
Operating gains losses ---10.25M------------------------------------
Depreciation and amortization 34.38%1.33M50.92%412K34.34%356K25.43%291K23.42%274K236.27%992K279.17%273K235.44%265K213.51%232K217.14%222K
Other non cash items 59.25%2.56M101.28%940K139.41%644K29.93%560K-5.94%412K145.04%1.61M125.60%467K-2.54%269K389.77%431K421.43%438K
Change In working capital -3,070.34%-88.04M-17,471.72%-93.83M-30.58%9.51M251.57%3.08M16.74%-6.8M-57.45%2.96M-119.63%-534K397.75%13.7M-132.99%-2.03M-74.82%-8.17M
-Change in receivables ---100M------------------0----------------
-Change in prepaid assets -1,065.70%-16.41M-1,458.18%-9.13M-201.87%-2.18M-102.57%-62K23.83%-5.05M65.12%-1.41M138.40%672K337.44%2.14M45.30%2.41M-117.60%-6.63M
-Change in payables and accrued expense 138.38%26.28M285.04%10.02M7.05%12.69M275.51%3.88M74.73%-307K-2.47%11.02M-42.82%2.6M219.43%11.85M-148.94%-2.21M17.79%-1.22M
-Change in other current assets 186.72%4.39M279.11%5.88M-10,025.00%-397K94.04%-106K-49,400.00%-990K-33,840.00%-5.06M-46,814.29%-3.28M--4K-2,296.30%-1.78M96.61%-2K
-Change in other current liabilities -44.31%-2.3M-15.30%-603K-107.96%-601K-40.35%-633K-39.94%-459K-405.08%-1.59M-636.62%-523K-407.02%-289K-374.74%-451K-256.52%-328K
Cash from discontinued investing activities
Operating cash flow -90.51%-222.2M-76.64%-64.42M-158.92%-51M-106.71%-54.56M-53.25%-52.23M-46.73%-116.64M-67.83%-36.47M4.19%-19.7M-56.23%-26.39M-67.82%-34.08M
Investing cash flow
Cash flow from continuing investing activities 125.02%89.8M68.93%56.14M73.91%-49.32M123.93%48.94M2,300.07%34.03M-33.75%-358.91M118.39%33.23M-727.45%-189.04M-197.65%-204.52M102.89%1.42M
Net PPE purchase and sale -180.16%-3.61M-9,250.00%-1.5M-129.49%-1.57M45.67%-232K-93.83%-314K40.47%-1.29M98.62%-16K16.46%-685K-123.56%-427K---162K
Net investment purchase and sale 126.12%93.41M88.87%62.79M71.91%-52.91M124.09%49.17M2,073.86%34.35M-34.35%-357.62M118.51%33.25M-708.61%-188.36M-197.85%-204.09M103.22%1.58M
Cash from discontinued investing activities
Investing cash flow 125.02%89.8M68.93%56.14M73.91%-49.32M123.93%48.94M2,300.07%34.03M-33.75%-358.91M118.39%33.23M-727.45%-189.04M-197.65%-204.52M102.89%1.42M
Financing cash flow
Cash flow from continuing financing activities 47.99%762.52M114,532.03%704.99M7,524.44%56.2M-99.90%517K15.24%809K14.11%515.26M-99.78%615K-260.04%-757K173,400.67%514.7M-99.59%702K
Net common stock issuance 29.37%665.71M--608.65M--57.06M--------8.95%514.57M--0--0--514.57M--0
Proceeds from stock option exercised by employees 3,900.24%99.45M15,767.80%97.59M-5.04%377K-28.09%517K27.81%965K210.75%2.49M425.64%615K-16.07%397K301.68%719K2,335.48%755K
Net other financing activities -46.88%-2.64M---1.25M-6.76%-1.23M--0-194.34%-156K91.67%-1.8M--0---1.15M-23.74%-589K97.96%-53K
Cash from discontinued financing activities
Financing cash flow 47.99%762.52M114,532.03%704.99M7,524.44%56.2M-99.90%517K15.24%809K14.11%515.26M-99.78%615K-260.04%-757K173,400.67%514.7M-99.59%702K
Net cash flow
Beginning cash position 30.60%169.51M-40.21%102.91M-61.47%147.02M55.49%152.12M30.60%169.51M397.46%129.79M239.94%172.13M840.18%381.63M-22.66%97.83M397.46%129.79M
Current changes in cash 1,486.47%630.11M26,692.02%696.71M78.94%-44.11M-101.80%-5.1M45.60%-17.39M-61.70%39.72M-103.31%-2.62M-2,185.58%-209.5M430.37%283.8M-131.83%-31.96M
End cash Position 371.73%799.62M371.73%799.62M-40.21%102.91M-61.47%147.02M55.49%152.12M30.60%169.51M30.60%169.51M239.94%172.13M840.18%381.63M-22.66%97.83M
Free cash flow -91.49%-225.81M-80.66%-65.91M-157.93%-52.57M-104.29%-54.79M-53.45%-52.54M-44.42%-117.93M-59.42%-36.48M4.66%-20.38M-56.98%-26.82M-68.61%-34.24M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 12 local time, U.S. Vice President Vance stated that negotiations between the United States and Iran failed to reach an agreement, Show More